InvestorsHub Logo
Followers 0
Posts 132
Boards Moderated 0
Alias Born 06/05/2016

Re: None

Thursday, 03/07/2019 1:20:00 PM

Thursday, March 07, 2019 1:20:00 PM

Post# of 34626
This stock reminds me of a prostate cancer drug that came from a company called Dendrion. A friend of mine bought shares at multiple times during the last phase clinical testing . Bought shares as the stock was tanking and finally when the day came for the FDA decision I think the stock had tanked to like $1.50 but the FDA approved the drug which showed an decrease in mortality rate that was significant to people with prostate cancer. The stock actually moved to $30.00 the first day of approval and eventually went to around $60.00 a share at the top end. He made a million on the stock. Is this the type of increase that MRKRTHERAPEUTIC could produce when the product gets approved or is this not a game changer. Phantom I can see your research is been phenomenal on this company but is it realistic to expect any major gains in value if these products make it to market. Thanks
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News